½ÃÀ庸°í¼­
»óǰÄÚµå
1602260

¼¼°èÀÇ »óó ºÀÇÕ ±â±â ½ÃÀå : Á¦Ç° À¯Çü, »óó À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Wound Closure Devices Market by Product (Adhesives, Mechanical Wound Closure Devices, Sealants), Wound Type (Acute Wounds, Chronic Wounds), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 185 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

»óó ºÀÇÕ±â±â ½ÃÀåÀº 2023³â¿¡ 179¾ï 7,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 192¾ï 7,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.44%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 297¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ »óó ºÀÇÕ ±â±â ½ÃÀåÀº ¼ö¼ú Àý°³, ¿­»ó ¹× ±âŸ »óó¸¦ ºÀÇÕ ¹× Ä¡À¯ÇÏ´Â µ¥ »ç¿ëµÇ´Â µµ±¸¿Í ±â¼ú·Î Ư¡ Áö¾îÁý´Ï´Ù. È¿°úÀûÀÎ »óó ºÀÇÕ ÀåºñÀÇ Çʿ伺Àº ¼ö¼ú Áõ°¡, ¿Ü»ó Áõ°¡, ½Å¼ÓÇϰí È¿°úÀûÀÎ Ä¡À¯¸¦ Á¦°øÇÏ´Â ±â¼úÀÇ Áøº¸¿¡ ÀÇÇØ Áö¿øµÇ°í ÀÖ½À´Ï´Ù. ¼ö¼ú¿¡¼­ ¹Ì¿ë ¼ºÇü¿¡ À̸£±â±îÁö ´Ù¾çÇÑ È¯ÀÚ ±×·ì ƯÈ÷, »óó ȸº¹ÀÌ ÀϹÝÀûÀ¸·Î ´À¸° ³ëÀÎ Àα¸ Áõ°¡°¡ ½ÃÀåÀ» µÞ¹ÞħÇϰí Çõ½ÅÀûÀÎ »óó ºÀÇÕ ¼Ö·ç¼Ç ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÃÀå ¼ºÀå ¿äÀÎÀ¸·Î´Â ¼ö¼úÀÇ ²ÙÁØÇÑ Áõ°¡, Èí¼ö¼º ºÀÇÕ»ç µîÀÇ ±â¼ú Áøº¸, Çコ Äɾî ÁöÃâÀÇ Áõ´ë µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå ±â¾÷°£ÀÇ Á¦ÈÞ³ª ÇÕº´ÀÌ Á¦Ç° °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ½ÅÈï ½ÃÀåÀº Å« ºñÁî´Ï½º Â÷ ±â¾÷Àº »ýºÐÇØ¼º ºÀÇÕ Àç·áÀÇ ¿¬±¸ °³¹ßÀ» ÅëÇØ Áö¿ª Àü·«°ú Á¦Ç°ÀÇ Â÷º°È­¿¡ ÅõÀÚÇÔÀ¸·Î½á À̵éÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä°Ç, º¹ÀâÇÑ °æÀï ±¸µµ µî Á¦¾àÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ Æ¯Á¤ Àåºñ¿Í °ü·ÃµÈ °¨¿° À§Çè°ú ³·Àº ÀÚ¿ø ȯ°æ¿¡¼­ ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·µµ °úÁ¦°¡µÇ¾ú½À´Ï´Ù. »óó Ä¡À¯¸¦ À§ÇÑ ³ª³ë±â¼úÀ̳ª Á¶Á÷°øÇÐÀÇ Á¶»çµµ ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡ÇÕ´Ï´Ù. º¯È­¸¦ Ç×»ó ÆÄ¾ÇÇÏ´Â °ÍÀÌ ÇʼöÀûÀÔ´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ Çõ½Å¿¡ ÁÖ·ÂÇÏ°í µðÁöÅÐ Ç÷§ÆûÀ» Ȱ¿ëÇÏ¿© ÀÎÁöµµ¸¦ ³ôÀÌ´Â °ÍÀ¸·Î ±â¾÷Àº ÃæÁ·µÇÁö ¾ÊÀº ¿ä±¸¸¦ ÆÄ°í ±× ¹ßÀÚ±¹À» ¼¼°è·Î È®´ëÇÏ´Â °Í ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 179¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 192¾ï 7,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 297¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 7.44%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â »óó ºÀÇÕ ±â±â ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

»óó ºÀÇÕ±â±â ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ¹× ±Þ¼º »óó ¹ß»ý·ü Áõ°¡
    • »óó Ä¡·á¿¡ °üÇÑ Á¤ºÎÀÇ ´ëó
    • ÇコÄɾî ÀÎÇÁ¶ó°¡ Á¤ºñµÈ °æÁ¦±Ç¿¡ À־ÀÇ È­»ó Ä¡·á ¼¾ÅÍÀÇ È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • »óó ºÀÇÕ ±â±âÀÇ °íºñ¿ë
  • ½ÃÀå ±âȸ
    • ¼±ÁøÀû »óó Ä¡·á ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¹ß
    • »óó ºÀÇÕ ±â±âÀÇ »ó¾÷È­¸¦ ÇâÇÑ Àΰ¡ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • »óó ºÀÇÕ ±â±âÀÇ »ç¿ë¿¡ ÀÇÇÑ ÇÕº´ÁõÀ̳ª ºÎÀÛ¿ëÀÇ °¡´É¼º

Porter's Five Force : »óó ºÀÇÕ ±â±â ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Force Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : »óó ºÀÇÕ ±â±â ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº »óó ºÀÇÕ ±â±â ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : »óó ºÀÇÕ ±â±â ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

»óó ºÀÇÕ Àåºñ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : »óó ºÀÇÕ ±â±â ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â »óó ºÀÇÕ Àåºñ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ³× °¡Áö »çºÐ¸éÀº °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ±¸ºÐÇÏ¿© »ç¿ëÀÚ°¡ Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â Á¾ÇÕÀûÀÎ ½ÃÀå ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ¾÷°è ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅ͸¦ Æ÷ÇÔÇÑ ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ¹× ±Þ¼º »óóÀÇ ¹ß»ý·üÀÌ Áõ°¡
      • »óó Ä¡·á¿¡ °üÇÑ Á¤ºÎÀÇ ´ëó
      • Çコ Äɾî ÀÎÇÁ¶óÀÇ °³¼±ÀÌ ÁøÇàµÇ´Â °æÁ¦±Ç¿¡ À־ÀÇ È­»ó Ä¡·á ¼¾ÅÍÀÇ È®´ë
    • ¾ïÁ¦¿äÀÎ
      • »óó ºÀÇÕ ±â±âÀÇ °íºñ¿ë
    • ±âȸ
      • ¼±ÁøÀûÀÎ »óó ÄÉ¾î ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¹ß
      • »óó ºÀÇÕ ±â±âÀÇ »óǰȭ¿¡ÀÇ Âùµ¿ÀÌ Áõ°¡
    • °úÁ¦
      • »óó ºÀÇÕ ±â±âÀÇ »ç¿ë¿¡ ¼ö¹ÝµÇ´Â ÇÕº´Áõ ¹× ÀϾ ¼ö ÀÖ´Â ºÎÀÛ¿ë
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • Á¦Ç° : »óó ºÀÇÕ ±â±â¿¡¼­ ºÀÇÕ»çÀÇ È£°¨µµ Áõ°¡
    • ¿ëµµ : ÀϹÝÀûÀÎ ¼ö¼ú¿¡ À־ »óó ºÀÇÕ ±â±âÀÇ »ç¿ëÀ» ´Ã·Á Ä¡À¯ ½Ã°£À» ´ÜÃàÇÑ´Ù
    • »óóÀÇ À¯Çü : ±Þ¼º »óóÀÇ Ä¡À¯¸¦ ÃËÁøÇϱâ À§ÇÑ »óó ºÀÇÕ ±â±âÀÇ Àû¿ëÀÌ È®´ë
    • ÃÖÁ¾»ç¿ëÀÚ: ¼ö¼úÀ» À§ÇÑ º´¿ø¿¡¼­ÀÇ »óó ºÀÇÕ ±â±âÀÇ Ã¤¿ë È®´ë
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå â»ó ºÀÇÕ ÀåÄ¡ ½ÃÀå : Á¦Ç°º°

  • Á¢ÂøÁ¦
    • ¾ÆÅ©¸±
    • »ý¹°ÇÐÀû Á¢ÂøÁ¦
    • Æú¸®¿ì·¹Åº
    • ½Ç¸®ÄÜ
  • ±â°è »óó ºÀÇÕ ±â±â
  • ½Ç¶õÆ®
    • Äݶó°Õº£À̽º
    • ºñÇÕ¼º
    • ÇÕ¼º
  • ½ºÅ×ÀÌÇýº
  • ½ºÆ®¸³
    • ºñ¸ê±Õ
    • ¸ê±Õ ¿Ï·á
  • ºÀÇÕ»ç
    • Èí¼ö¼º
    • ºñÈí¼ö¼º

Á¦7Àå â»ó ºÀÇÕ ÀåÄ¡ ½ÃÀå : â»ó À¯Çüº°

  • ±Þ¼º »óó
  • ¸¸¼º »óó

Á¦8Àå â»ó ºÀÇÕ ÀåÄ¡ ½ÃÀå : ¿ëµµº°

  • È­»ó
  • ½ÉÀ庴ÇÐ
  • ´ç´¢º´¼º ¹ß ±Ë¾ç
  • ÀÏ¹Ý ¼ö¼ú
  • ºÎÀΰú
  • ¾È°ú
  • Á¤Çü¿Ü°ú

Á¦9Àå â»ó ºÀÇÕ ÀåÄ¡ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • È­»ó ÄÉ¾î ¼¾ÅÍ
  • Ŭ¸®´Ð
  • ÀçÅà Äɾî ȯ°æ
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä« »óó ºÀÇÕ±â±â ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾ç â»óºÀÇÕ±â±â ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ »óó ºÀÇÕ ±â±â ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023³â
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023³â
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • MediWound, EscharEx Á¦3»ó ½ÃÇè¿¡¼­ 3M°ú Á¦ÈÞ¸¦ ¹ßÇ¥
    • SYNDEO MedicalÀÌ Closex Medical, Inc.¿ÍÀÇ ¿©·¯ ÇØ¿¡ °ÉÄ£ Àü·«Àû ÆÇ¸Å °è¾àÀ» ¹ßÇ¥
    • Coloplast A/S, »óó Äɾî ȸ»ç Kerecis¸¦ 13¾ï ´Þ·¯·Î Àμö
    • EvonikÀÇ JeNaCellÀÌ ¸¸¼º â»ó¿ëÀÇ »óó ÇǺ¹Àç Epicite Balance¸¦ ¹ß¸Å
    • Tube Investments, Premji Invest°¡ Á¦ÈÞÇØ, Lotus Surgicals¸¦ 348Ä®·Î¸£ Àεµ ·çÇÇ·Î Àμö
    • Bactiguard, ¿µ±¹°ú ¾ÆÀÏ·£µå¿¡¼­ »óó Äɾî Á¦Ç° ¶óÀÎÀ» ¹ß¸Å
    • KitoTech Medical Inc.°¡ Synergy Corporation°ú ÀÇ·á ¹× ¼ÒºñÀÚ¿ë Á¦Ç°ÀÇ ±¹Á¦ ÆÇ¸Å °è¾àÀ» ü°á
    • Gentell, Inc., Integra LifeSciences Holdings CorporationÀÇ ºñÁßÇÙ ÀüÅë »óó ÄÉ¾î »ç¾÷ Àμö ¿Ï·á
    • Ç×±Õ ºÀÇÕ»çÀÇ ¼Ò°³
    • AMS, »õ·Î¿î »óó ºÀÇÕ ±â±â·Î FDAÀÇ Àΰ¡¸¦ Ãëµæ
    • KitoTech MedicalÀÌ Corza Medical°ú °è¾àÀ» ü°áÇϰí microMend PRO »óó ºÀÇÕ ±â±â¸¦ ¹Ì±¹¿¡¼­ ÆÇ¸Å
    • Triad Life Sciences Inc.ÀÇ Àμö¿¡ ÀÇÇØ ¸Å·ÂÀûÀÎ »óó »ý¹°ÇÐÀû Á¦Á¦ ºÐ¾ß¿¡ Âü°¡

±â¾÷ ¸ñ·Ï

  • Medela AG
  • Arthrex, Inc.
  • DUKAL Corporation
  • RedDress Medical Ltd.
  • Teleflex Incorporated
  • Baxter International Inc.
  • Bactiguard AB
  • Johnson & Johnson Services, Inc.
  • Spectral AI, Inc.
  • 3M Company
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Molnlycke Health Care AB
  • Clozex Medical, Inc.
  • Harro Hofliger Verpackungsmaschinen GmbH
  • DermaClip US, LLC
  • DuPont de Nemours, Inc.
  • McKesson Corporation
  • Dolphin Sutures by Futura Surgicare Pvt Ltd
  • DermaRite Industries, LLC
  • B. Braun SE
  • Riverpoint Medical
  • Advanced Medical Solutions Group PLC
  • Coloplast A/S
  • SYLKE
  • Evonik Industries AG
  • Inotec AMD Limited
  • Healiva SA
  • Sky Medical Technology Ltd.
  • Integra LifeSciences Holdings Corporation
  • Convatec Group PLC
  • MediWound
  • DeRoyal Industries, Inc.
  • Cardinal Health, Inc.
  • Artivion, Inc.
  • Smith & Nephew PLC
  • Becton, Dickinson and Company
  • Medtronic PLC
  • Stryker Corporation
  • Medline Industries, LP
  • Gentell
JHS 24.12.12

The Wound Closure Devices Market was valued at USD 17.97 billion in 2023, expected to reach USD 19.27 billion in 2024, and is projected to grow at a CAGR of 7.44%, to USD 29.71 billion by 2030.

The global wound closure devices market is characterized by tools and techniques used to close and heal surgical incisions, lacerations, or other wound types. These include sutures, staples, hemostatic agents, adhesives, and sealants. The need for effective wound closure devices is underpinned by increasing surgical procedures, a rise in traumatic injuries, and advancements in technology offering rapid and effective healing. Applications span across hospitals, clinics, and ambulatory surgical centers, targeting a diverse patient group from general surgeries to cosmetic procedures. Notably, the market is bolstered by a growing elderly population, who typically experience slower wound recovery, thus driving demand for innovative closure solutions. Key factors influencing growth include the steady rise in surgical procedures, technological advancements like absorbable sutures, and augmented healthcare expenditure. Additionally, collaborations and mergers among market players are fostering product development. Emerging markets, with evolving healthcare infrastructure and increasing awareness, offer significant opportunities. Firms could capitalize on these by investing in localized strategies and product differentiation through R&D in biodegradable closure materials. However, limitations include the high cost of advanced devices, stringent regulatory requirements, and the complex competitive landscape. Challenges also extend to the risk of infections associated with certain devices and a lack of skilled professionals in low-resource settings. Opportunities for innovation lie in bioactive wound closure materials and smart wound care technologies that provide real-time monitoring. Research into nanotechnology and tissue engineering for wound healing can also spur growth. The market is dynamic with constant innovation, making it essential for companies to stay abreast of technological advancements and evolving consumer needs. By focusing on cost-effective innovations and leveraging digital platforms for awareness, businesses can tap into unmet needs and expand their footprint globally.

KEY MARKET STATISTICS
Base Year [2023] USD 17.97 billion
Estimated Year [2024] USD 19.27 billion
Forecast Year [2030] USD 29.71 billion
CAGR (%) 7.44%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wound Closure Devices Market

The Wound Closure Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing incidence of chronic and acute wounds among people
    • Government initiatives regarding wound care treatment
    • Expansion of burn-care centers in economies with improving healthcare infrastructure
  • Market Restraints
    • High cost of wound closure device
  • Market Opportunities
    • Ongoing development of advanced wound care technologies
    • Rising approvals for the commercialization of wound closure devices
  • Market Challenges
    • Complications and probable side effect with the use of wound closure device

Porter's Five Forces: A Strategic Tool for Navigating the Wound Closure Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wound Closure Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wound Closure Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wound Closure Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wound Closure Devices Market

A detailed market share analysis in the Wound Closure Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wound Closure Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wound Closure Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Wound Closure Devices Market, highlighting leading vendors and their innovative profiles. These include Medela AG, Arthrex, Inc., DUKAL Corporation, RedDress Medical Ltd., Teleflex Incorporated, Baxter International Inc., Bactiguard AB, Johnson & Johnson Services, Inc., Spectral AI, Inc., 3M Company, Boston Scientific Corporation, Abbott Laboratories, Molnlycke Health Care AB, Clozex Medical, Inc., Harro Hofliger Verpackungsmaschinen GmbH, DermaClip US, LLC, DuPont de Nemours, Inc., McKesson Corporation, Dolphin Sutures by Futura Surgicare Pvt Ltd, DermaRite Industries, LLC, B. Braun SE, Riverpoint Medical, Advanced Medical Solutions Group PLC, Coloplast A/S, SYLKE, Evonik Industries AG, Inotec AMD Limited, Healiva SA, Sky Medical Technology Ltd., Integra LifeSciences Holdings Corporation, Convatec Group PLC, MediWound, DeRoyal Industries, Inc., Cardinal Health, Inc., Artivion, Inc., Smith & Nephew PLC, Becton, Dickinson and Company, Medtronic PLC, Stryker Corporation, Medline Industries, LP, and Gentell.

Market Segmentation & Coverage

This research report categorizes the Wound Closure Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Adhesives, Mechanical Wound Closure Devices, Sealants, Staples, Strips, and Sutures. The Adhesives is further studied across Acrylics, Biological Adhesives, Polyurethanes, and Silicone. The Sealants is further studied across Collagen Based, Non-Synthetic, and Synthetic. The Strips is further studied across Non-Sterile and Sterile. The Sutures is further studied across Absorbable and Non-Absorbable.
  • Based on Wound Type, market is studied across Acute Wounds and Chronic Wounds.
  • Based on Application, market is studied across Burns, Cardiology, Diabetic Foot Ulcers, General Surgery, Gynaecology, Ophthalmic, and Orthopedics.
  • Based on End-User, market is studied across Burn Care Centers, Clinics, Home Care Setting, and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across Alaska, California, Florida, Illinois, Massachusetts, Michigan, Montana, Nevada, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of chronic and acute wounds among people
      • 5.1.1.2. Government initiatives regarding wound care treatment
      • 5.1.1.3. Expansion of burn-care centers in economies with improving healthcare infrastructure
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of wound closure device
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing development of advanced wound care technologies
      • 5.1.3.2. Rising approvals for the commercialization of wound closure devices
    • 5.1.4. Challenges
      • 5.1.4.1. Complications and probable side effect with the use of wound closure device
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rising preference for sutures in wound closure devices
    • 5.2.2. Application: Increasing usage of wound closure devices in general surgery for faster healing times
    • 5.2.3. Wound Type: Growing application of wound closure devices for acute wounds to promote healing
    • 5.2.4. End-User: Expanding adoption of wound closure devices in hospitals for surgical procedures
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wound Closure Devices Market, by Product

  • 6.1. Introduction
  • 6.2. Adhesives
    • 6.2.1. Acrylics
    • 6.2.2. Biological Adhesives
    • 6.2.3. Polyurethanes
    • 6.2.4. Silicone
  • 6.3. Mechanical Wound Closure Devices
  • 6.4. Sealants
    • 6.4.1. Collagen Based
    • 6.4.2. Non-Synthetic
    • 6.4.3. Synthetic
  • 6.5. Staples
  • 6.6. Strips
    • 6.6.1. Non-Sterile
    • 6.6.2. Sterile
  • 6.7. Sutures
    • 6.7.1. Absorbable
    • 6.7.2. Non-Absorbable

7. Wound Closure Devices Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Acute Wounds
  • 7.3. Chronic Wounds

8. Wound Closure Devices Market, by Application

  • 8.1. Introduction
  • 8.2. Burns
  • 8.3. Cardiology
  • 8.4. Diabetic Foot Ulcers
  • 8.5. General Surgery
  • 8.6. Gynaecology
  • 8.7. Ophthalmic
  • 8.8. Orthopedics

9. Wound Closure Devices Market, by End-User

  • 9.1. Introduction
  • 9.2. Burn Care Centers
  • 9.3. Clinics
  • 9.4. Home Care Setting
  • 9.5. Hospital

10. Americas Wound Closure Devices Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Wound Closure Devices Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Wound Closure Devices Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. MediWound Announces Collaboration with 3M on EscharEx Phase III Study
    • 13.3.2. SYNDEO Medical Announces Multi-Year Strategic Distribution Agreement with Clozex Medical, Inc.
    • 13.3.3. Coloplast A/S to Acquire Wound Care Company Kerecis for USD 1.3 Billion
    • 13.3.4. Evonik Company JeNaCell Launches Wound Dressing Epicite Balance for Chronic Wounds
    • 13.3.5. Tube Investments, Premji Invest Partner Up To Acquire Lotus Surgicals For INR 348 Crore
    • 13.3.6. Bactiguard Launches Wound Care Line in the UK and Ireland
    • 13.3.7. KitoTech Medical Inc. Signs Agreement with Synergy Corporation for International Distribution of Their Medical and Consumer Products
    • 13.3.8. Gentell, Inc. Completed the Acquisition of Non-Core Traditional Wound Care Business of Integra LifeSciences Holdings Corporation
    • 13.3.9. Introducing Antibacterial Suture Range
    • 13.3.10. AMS Receives FDA Clearance for New Wound Closure Device
    • 13.3.11. KitoTech Medical Signs Agreement with Corza Medical to Market microMend PRO Wound Closure Devices in the U.S.
    • 13.3.12. Entry Into the Attractive Wound Biologics Segment Through the Acquisition of Triad Life Sciences Inc.

Companies Mentioned

  • 1. Medela AG
  • 2. Arthrex, Inc.
  • 3. DUKAL Corporation
  • 4. RedDress Medical Ltd.
  • 5. Teleflex Incorporated
  • 6. Baxter International Inc.
  • 7. Bactiguard AB
  • 8. Johnson & Johnson Services, Inc.
  • 9. Spectral AI, Inc.
  • 10. 3M Company
  • 11. Boston Scientific Corporation
  • 12. Abbott Laboratories
  • 13. Molnlycke Health Care AB
  • 14. Clozex Medical, Inc.
  • 15. Harro Hofliger Verpackungsmaschinen GmbH
  • 16. DermaClip US, LLC
  • 17. DuPont de Nemours, Inc.
  • 18. McKesson Corporation
  • 19. Dolphin Sutures by Futura Surgicare Pvt Ltd
  • 20. DermaRite Industries, LLC
  • 21. B. Braun SE
  • 22. Riverpoint Medical
  • 23. Advanced Medical Solutions Group PLC
  • 24. Coloplast A/S
  • 25. SYLKE
  • 26. Evonik Industries AG
  • 27. Inotec AMD Limited
  • 28. Healiva SA
  • 29. Sky Medical Technology Ltd.
  • 30. Integra LifeSciences Holdings Corporation
  • 31. Convatec Group PLC
  • 32. MediWound
  • 33. DeRoyal Industries, Inc.
  • 34. Cardinal Health, Inc.
  • 35. Artivion, Inc.
  • 36. Smith & Nephew PLC
  • 37. Becton, Dickinson and Company
  • 38. Medtronic PLC
  • 39. Stryker Corporation
  • 40. Medline Industries, LP
  • 41. Gentell
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦